The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung Patients

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Jul 25, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how exercise training can impact the quality of life and progression of fibrosing interstitial lung disease, a condition that affects the lungs and makes it hard to breathe. Over the course of one year, researchers will compare two groups of patients: one group will participate in a special exercise program designed for lung health, while the other group will not receive this training. The goal is to see if the exercise program helps improve their everyday life and slows down the disease.

To be eligible for this trial, participants need to be between 18 and 75 years old and have a diagnosis of fibrosing interstitial lung disease. They should also experience shortness of breath when being active and be in stable health without any recent infections. Participants will need to be comfortable using a smartphone to help with the study. Those with serious other health issues or who have recently completed a similar exercise program will not be able to join. If you decide to participate, you can expect regular assessments of your health and quality of life throughout the year, which will help researchers understand the benefits of exercise for people with this lung condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged between 18-75 years
• • Diagnosed with fibrosing interstitial lung disease according to the clinical diagnostic criteria of the American Thoracic Society and European Respiratory Society (ATS-ERS)
• • Presence of dyspnea on exertion
• • Stable clinical condition at the time of inclusion without infection or exacerbation in the previous 4 weeks
• • Proficiency in using a smartphone
• Exclusion Criteria:
• • Severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases, or requiring high-flow oxygen therapy (\> 3-4 L/min)
• • History of exertional syncope or any comorbidity that prevents exercise training (such as severe orthopedic or neurological deficits or unstable heart disease)
• • Participation in a pulmonary rehabilitation program within the last 12 months